Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Operative PLD, Paclitaxel, and Trastuzumab in HER2+ Breast Cancer
NCT00518583Phase 2Unknown
- Sponsor
- Aptium Oncology
- Start
- Oct 2006
- Primary completion
- Jan 2009
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by Aptium Oncology. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00518583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518583.